Jump to content

epfeiffer

Members
  • Posts

    23
  • Joined

  • Last visited

  • Country

    United States

About epfeiffer

  • Birthday 04/25/1980

Profile Information

  • Gender
    Female
  • Interests
    Skiing, running, horseback riding, reading, blood banking
  • Location
    Flagstaff, AZ
  • Occupation
    Blood Bank Lead Technologist
  • Real Name
    erin pfeiffer

epfeiffer's Achievements

  1. We do perform both activities. Since we had already validated the system for transport of all other products, we validated syringes by ensuring that when they were sent they wouldn't leak or break. We also add a little additional padding to the tubes with syringes to guarantee they are held in place.
  2. I apologize if this topic has already been asked, I searched and couldn't find it! I have a trauma helicopter that wants to start carrying red cells (United States). I am concerned about the possible regulatory issues surrounding this process. We discussed most of my concerns. However, when I asked about a patient specimen for crossmatching I was informed that no there hospitals that provides this service has ever requested a sample. I was always under the impression we had to perform crossmatches on blood we release in emergency situations, I consulted my medical director and he was on the same page. There is always the possibility that I am reading too much into the FDA CFR/AABB Standards and perhaps there is a more flexible interpretation. Would someone please let me know if you see this differently?
  3. Is there any FDA approved disinfectants for cleaning the bags? I have an ID doc who said if I have the IFU for the product I should be able to see any approved disinfectants. The only issue is, they are not my bags and I don't necessarily have the manufacturer's information. Any thoughts?
  4. My sister hospital also uses API for their surveys and has had the same problems with their Anti-Ds. The new Policy is to replace the reagents after two weeks. They have also instituted a policy to test all new D negative patients/samples on the bench. They are using the exact same reagents on the bench and getting the expected reactivity, while on the Echo it was negative...weird
  5. Albaugh, we have Cerner Milenium, and you may be right it may be just as easy, I just took over and haven't had a chance to investigate.
  6. The only way I was able to determine which units left the blood bank for the MTP and trauma pack was by looking at the segments which were appropriately labeled. The nursing record correctly identified all transfused components. None of my records correctly identified the three units in question. The blood is not labeled with a patient name because we often won't have a patient name until after we deliver the blood.
  7. The paperwork with the units was not correct, it was a carbon to what we issued. We use Cerner
  8. Hi, I am having a slight disagreement with my manager. We recently had a trauma that required an MTP. Initially we complete all the issuing of blood products on paper as our computer system makes releasing uncrossmatched blood very cumbersome in an emergency, especially when we may not necessarily have a name right away. When I went to review the paper work I found that one unit had been recorded twice (it was not a split), one unit had then been omitted, and two donation numbers were incorrectly recorded. The units were all released to nursing staff, one unit was transfused and the other two were returned. I feel this is a reportable error. He feels that because this is administrative that it shouldn't be reportable. I am frustrated.
  9. I see you are switching to the Echo. I have noticed that dosage is the norm on this platform. I have changed my rule out policy to be 2 homozygous cells to rule out C,c,E,e,Fya, Fyb, Jka, Jkb,M,N,S, and s. We have almost missed a couple of kidds by only ruling out with 1 homozygous cell.
  10. We just had this debate at my facility. There is another thread here which contained a survey as to how other people are handling this exact issue. I believe a majority of people polled were calling any positive reaction D positive. Then there were a few people who were calling it negative with a comment. That thread had more to do with Rhogam I believe.
  11. I know I'm a little late responding to this thread, but I didn't see the answer I would've provided, so I thought it worth mentioning. When we would EGA treat a neonate red cell to rule out weak D we would run a drop of EGA treated red cell with an in house 6% albumin as our negative control. The control served the purpose of verifying positive reactions were truly due to the presence of the antigen and not the result of an incompletely removed maternal IgG. We did do an extensive validation prior to using the EGA kit however, verifying which antigens were denatured, so we had complete confidence the D antigen was left intact. (Immucor was correct by the way, and the validation was completely unnecessary.)
  12. Why are you doing a CRP in the first place? If the answer to that is because some disease or disease process is being investigate which would result in a deferral, than that patient should be deferred. In my experience that test is ordered for a specific reason, not as a screening test.
  13. Does this take into account the fact that our plasma is not necessarily leukocyte reduced? Or does this even matter?
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.